Regencell Bioscience Holdings Limited (RGC) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RGC Revenue Growth
RGC Revenue Analysis (2019–2024)
As of May 8, 2026, Regencell Bioscience Holdings Limited (RGC) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q2 2025) recorded $0 in revenue.
Looking at the longer-term picture, RGC's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including NUVB (+1205.5% YoY), AEYE (+14.5% YoY), and SIGA (-22.1% YoY). Compare RGC vs NUVB →
RGC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RGCCurrent | $0 | - | - | - | |
 NUVB | $63M | +1205.5% | - | -338.7% | |
 AEYE | $40M | +14.5% | +14.5% | -7.9% | |
 SIGA | $95M | -22.1% | -5.4% | 25.1% |
RGC Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-745,588 | - | $-4,736,726 | - |
| 2023 | $0 | - | $-769,687 | - | $-6,273,671 | - |
| 2022 | $0 | - | $-604,397 | - | $-7,617,770 | - |
| 2021 | $0 | - | $-26,456 | - | $-1,381,362 | - |
| 2020 | $0 | - | $-9,516 | - | $-812,371 | - |
| 2019 | $0 | - | $0 | - | $-390,990 | - |
Full RGC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RGC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RGC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RGC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRGC — Frequently Asked Questions
Quick answers to the most common questions about buying RGC stock.
Is RGC's revenue growth accelerating or slowing?
RGC TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RGC's long-term revenue growth rate?
Regencell Bioscience Holdings Limited's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RGC's revenue distributed by segment?
RGC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.